Laboratory diagnosis of congenital toxoplasmosis

Journal of Clinical Microbiology

Volumn 54, Issue 10, 2016, Pages 2448-2454

  Pomares, Christelle ^a,b,c,d   Montoya, Jose G ^a,b  

^a PALO ALTO MEDICAL FOUNDATION   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PYRIMETHAMINE; SPIRAMYCIN; SULFONAMIDE;

AMNION FLUID; CEREBROSPINAL FLUID ANALYSIS; CONGENITAL TOXOPLASMOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; HUMORAL IMMUNITY; LABORATORY DIAGNOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PERINATAL PERIOD; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SHORT SURVEY; TOXOPLASMA GONDII; DIAGNOSTIC TEST; LABORATORY TECHNIQUE; PROCEDURES; SEROLOGY; TOXOPLASMOSIS, CONGENITAL;

CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; HUMANS; SEROLOGIC TESTS; TOXOPLASMOSIS, CONGENITAL;

EID: 84991219296     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00487-16     Document Type: Short Survey

References (38)

1. Wolf A, Cowen D, Paige B. 1939. Human toxoplasmosis: occurrence in infants as an encephalomyelitis verification by transmission to animals. Science 89:226-227. http://dx.doi.org/10.1126/science.89.2306.226.
2. Ferguson DJP. 2009. Toxoplasma gondii: 1908-2008, homage to Nicolle, Manceaux and Splendore. Mem Inst Oswaldo Cruz 104:133-148. http://dx.doi.org/10.1590/S0074-02762009000200003.
3. Peyron F, Wallon M, Kieffer F, Garweg JG. 2015. Toxoplasmosis, p. 949-1042. In Wilson CB, Nizet V, Maldonado Y, Remington JS, Klein JO (ed), Remington and Klein's infectious diseases of the fetus and newborn infant. Elsevier Health Sciences, Oxford, United Kingdom.
4. Torgerson PR, Mastroiacovo P. 2013. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 91:501-508. http://dx.doi.org/10.2471/BLT.12.111732.
5. Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE, European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). 2010. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med 7:e1000351. http://dx.doi.org/10.1371/journal.pmed.1000351.
6. Hotop A, Hlobil H, Gross U. 2012. Efficacy of rapid treatment initiation following primary Toxoplasma gondii infection during pregnancy. Clin Infect Dis 54:1545-1552. http://dx.doi.org/10.1093/cid/cis234.
7. Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J. 2008. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J 27:27-32. http://dx.doi.org/10.1097/INF.0b013e318134286d.
8. Prusa A-R, Kasper DC, Pollak A, Gleiss A, Waldhoer T, Hayde M. 2015. The Austrian toxoplasmosis register, 1992-2008. Clin Infect Dis 60:e4-e10. http://dx.doi.org/10.1093/cid/ciu724.
9. Wallon M, Peyron F, Cornu C, Vinault S, Abrahamowicz M, Kopp CB, Binquet C. 2013. Congenital Toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years. Clin Infect Dis 56:1223-1231. http://dx.doi.org/10.1093/cid/cit032.
10. SYROCOT (Systematic Review on Congenital Toxoplasmosis) Study Group, Thiébaut R, Leproust S, Chêne G, Gilbert R. 2007. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369:115-122. http://dx.doi.org/10.1016/S0140-6736(07)60072-5.
11. Bessières MH, Berrebi A, Rolland M, Bloom MC, Roques C, Cassaing S, Courjault C, Séguéla JP. 2001. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynecol Reprod Biol 94:37-45. http://dx.doi.org/10.1016/S0301-2115(00)00300-6.
12. Gilbert RE, Thalib L, Tan HK, Paul M, Wallon M, Petersen E, European Multicentre Study on Congenital Toxoplasmosis. 2007. Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth. J Med Screen 14:8-13. http://dx.doi.org/10.1258/096914107780154440.
13. Wallon M, Dunn D, Slimani D, Girault V, Gay-Andrieu F, Peyron F. 1999. Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA? Eur J Pediatr 158:645-649. http://dx.doi.org/10.1007/s004310051168.
14. Naessens A, Jenum PA, Pollak A, Decoster A, Lappalainen M, Villena I, Lebech M, Stray-Pedersen B, Hayde M, Pinon JM, Petersen E, Foulon W. 1999. Diagnosis of congenital toxoplasmosis in the neonatal period: a multicenter evaluation. J Pediatr 135:714-719. http://dx.doi.org/10.1016/S0022-3476(99)70090-9.
15. Montoya JG. 2002. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis 185(Suppl):S73-S82. http://dx.doi.org/10.1086/338827.
16. Villard O, Cimon B, L'Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E. 2016. Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis 84:22-33. http://dx.doi.org/10.1016/j.diagmicrobio.2015.09.009.
17. Murat J-B, Hidalgo HF, Brenier-Pinchart M-P, Pelloux H. 2013. Human toxoplasmosis: which biological diagnostic tests are best suited to which clinical situations? Expert Rev Anti Infect Ther 11:943-956. http://dx.doi.org/10.1586/14787210.2013.825441.
18. Moncada PA, Montoya JG. 2012. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment. Expert Rev Anti Infect Ther 10:815-828. http://dx.doi.org/10.1586/eri.12.58.
19. Olariu TR, Remington JS, Montoya JG. 2014. Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J 33:566-570. http://dx.doi.org/10.1097/INF.0000000000000256.
20. Pinon JM, Dumon H, Chemla C, Franck J, Petersen E, Lebech M, Zufferey J, Bessieres MH, Marty P, Holliman R, Johnson J, Luyasu V, Lecolier B, Guy E, Joynson DH, Decoster A, Enders G, Pelloux H, Candolfi E. 2001. Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol 39:2267-2271. http://dx.doi.org/10.1128/JCM.39.6.2267-2271.2001.
21. Murat JB, Souvignet A, Fricker-Hidalgo H, Brenier-Pinchart MP, Bost-Bru C, Pelloux H. 2015. Assessment of the IgA immunosorbent agglutination assay for the diagnosis of congenital toxoplasmosis on a series of 145 toxoplasmic seroconversions. Clin Vaccine Immunol 22:456-458. http://dx.doi.org/10.1128/CVI.00666-14.
22. Foudrinier F, Villena I, Jaussaud R, Aubert D, Chemla C, Martinot F, Pinon JM. 2003. Clinical value of specific immunoglobulin E detection by enzyme-linked immunosorbent assay in cases of acquired and congenital toxoplasmosis. J Clin Microbiol 41:1681-1686. http://dx.doi.org/10.1128/JCM.41.4.1681-1686.2003.
23. Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG. 2011. Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J 30:1056-1061. http://dx.doi.org/10.1097/INF.0b013e3182343096.
24. di Carlo P, Romano A, Casuccio A, Cillino S, Schimmenti MG, Mancuso G, la Chiusa S, Novara V, Ingrassia D, Li Vecchi V, Trizzino M, Titone L. 2011. Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study. Acta Pharmacol Sin 32:1063-1070. http://dx.doi.org/10.1038/aps.2011.55.
25. Robert-Gangneux F, Commerce V, Tourte-Schaefer C, Dupouy-Camet J. 1999. Performance of a Western blot assay to compare mother and newborn anti-Toxoplasma antibodies for the early neonatal diagnosis of congenital toxoplasmosis. Eur J Clin Microbiol Infect Dis 18:648-654. http://dx.doi.org/10.1007/s100960050366.
26. Machado AS, Andrade GMQ, Januário JN, Fernandes MD, Carneiro ACAV, Carneiro M, Carellos EVM, Romanelli RMC, Vasconcelos-Santos DV, Vitor RWA. 2010. IgG and IgM Western blot assay for diagnosis of congenital toxoplasmosis. Mem Inst Oswaldo Cruz 105:757-761.
27. Chapey E, Wallon M, L'Ollivier C, Piarroux R, Peyron F. 2015. Place of interferon-γ assay for diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J 34:1407-1409. http://dx.doi.org/10.1097/INF.0000000000000901.
28. Chapey E, Meroni V, Kieffer F, Bollani L, Ecochard R, Garcia P, Wallon M, Peyron F. 2015. Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis. Clin Vaccine Immunol 22:398-403. http://dx.doi.org/10.1128/CVI.00552-14.
29. Campello Porto L, Duarte EC. 2012. Association between the risk of congenital toxoplasmosis and the classification of toxoplasmosis in pregnant women and prenatal treatment in Brazil, 1994-2009. Int J Infect Dis 16:e480-e486. http://dx.doi.org/10.1016/j.ijid.2012.01.016.
30. Dhakal R, Gajurel K, Pomares C, Talucod J, Press CJ, Montoya JG. 2015. Significance of a positive Toxoplasma immunoglobulin M test result in the United States. J Clin Microbiol 53:3601-3605. http://dx.doi.org/10.1128/JCM.01663-15.
31. Montoya JG, Berry A, Rosso F, Remington JS. 2007. The differential agglutination test as a diagnostic aid in cases of toxoplasmic lymphadenitis. J Clin Microbiol 45:1463-1468. http://dx.doi.org/10.1128/JCM.01781-06.
32. Zhang B, Jarrell JA, Price JV, Tabakman SM, Li Y, Gong M, Hong G, Feng J, Utz PJ, Dai H. 2013. An integrated peptide-antigen microarray on plasmonic gold films for sensitive human antibody profiling. PLoS One 8:e71043. http://dx.doi.org/10.1371/journal.pone.0071043.
33. Zhang B, Kumar RB, Dai H, Feldman BJ. 2014. A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes. Nat Med 20:948-953. http://dx.doi.org/10.1038/nm.3619.
34. Naot Y, Desmonts G, Remington JS. 1981. IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital Toxoplasma infection. J Pediatr 98:32-36. http://dx.doi.org/10.1016/S0022-3476(81)80528-8.
35. Rodrigues IM, Costa TL, Avelar JB, Amaral WN, Castro AM, Avelino MM. 2014. Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy. BMC Infect Dis 14:349. http://dx.doi.org/10.1186/1471-2334-14-349.
36. Gandilhon F, Peyle L, Wallon M, Peyron F, Mojon M. 1994. Value of a specific IgA assay on cord blood for the diagnosis of congenital toxoplasmosis. Serodiagn Immunother Infect Dis 6:17-20. http://dx.doi.org/10.1016/0888-0786(94)90004-3.
37. Bessières MH, Berrebi A, Cassaing S, Fillaux J, Cambus JP, Berry A, Assouline C, Ayoubi JM, Magnaval JF. 2009. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem Inst Oswaldo Cruz 104:389-392. http://dx.doi.org/10.1590/S0074-02762009000200038.
38. L'Ollivier C, Wallon M, Faucher B, Piarroux R, Peyron F, Franck J. 2012. Comparison of mother and child antibodies that target high-molecular-mass Toxoplasma gondii antigens by immunoblotting improves neonatal diagnosis of congenital toxoplasmosis. Clin Vaccine Immunol 19:1326-1328. http://dx.doi.org/10.1128/CVI.00060-12.